Murphy USA Director and Chairman Sells $24.77 Million in Stock After Strong Q1
MUSA sits 67% above its 52-week low of $345.23.
Summary
A Director and Board Chairman at Murphy USA sold $24.77 million worth of company stock, confirming the execution of prior intent to sell following the company's strong Q1 earnings report.
Key Events · Ownership and Investor Activity · MUSA
-
Senior Insider Sells Significant Stake
Robert Madison Murphy, a Director and Board Chairman, disposed of 41,500 shares of Murphy USA common stock for a total value of $24,773,950.
-
Follows Strong Q1 Earnings
This substantial sale occurred on May 4, 2026, shortly after Murphy USA reported robust Q1 2026 financial results with net income more than doubling.
-
Execution of Prior Intent
This Form 4 confirms the actual sale of shares for which intent was previously filed via Form 144s on the same date, indicating the completion of the planned disposition.
Analysis · MUSA · Trade & Services
Robert Madison Murphy, a Director and the Board Chairman of Murphy USA, executed a substantial sale of 41,500 shares totaling $24.77 million. This transaction, conducted through a trust, follows the company's recent report of significantly improved Q1 2026 financial results, where net income more than doubled. The sale represents a notable disposition by a senior insider, confirming the execution of previously filed intent to sell via Form 144s on the same date. This adds to a pattern of insider distribution observed over the past 90 days.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 35.4% of the 1170 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MUSA was trading at $576.37 on NYSE in the Trade & Services sector, with a market capitalization of approximately $10.7B. The 52-week trading range was $345.23 to $609.82. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.